News

In a monumental leap for Latin American agricultural commerce, Costa Rica has officially planted its flag in the lucrative global medical cannabis trade. Marking an unprecedented economic and scientific milestone, the nation has successfully completed its inaugural export of pharmaceutical-grade, GACP-certified medical cannabis to the European Union.

This historic achievement not only opens a highly promising revenue stream for the country but also positions Costa Rica as a rising powerhouse in the international pharmaceutical-grade natural medicine market.

As per Astute Analytica, Europe medical cannabis oil market was valued at US$ 905.56 million in 2023 and is projected to hit the market valuation of US$ 2,395.83 million by 2032 at a CAGR of 12.8% during the forecast period 2024–2032.

Leading the Charge: Hybrida Farms Makes History

The trailblazer behind this landmark breakthrough is Hybrida Farms, the brand name for the Costa Rican licensed operator Vantage Point Global CR S.A. (operating under Vantage Point Global, Corp.).

Setting a new benchmark for pharmaceutical agriculture in Latin America, Hybrida Farms successfully dispatched the landmark shipment from Costa Rica on March 13, 2026. By navigating the stringent quality requirements of the European Union, the company has proven that Costa Rica is ready to compete at the highest levels of the global cannabis supply chain.

Unprecedented Authority: The Power of Dual Licensing

Hybrida Farms operates in a league of its own. It holds the prestigious distinction of being Costa Rica’s first and only dual-licensed operator authorized to cultivate both THC medical cannabis and industrial hemp.

This highly coveted operational status is backed by approvals from the nation's highest regulatory bodies, including:

• The Ministry of Agriculture and Livestock (MAG)
• The Ministry of Health
• The Costa Rican Institute on Drugs (ICD)

Furthermore, the export was certified under GACP (Good Agricultural and Collection Practice) guidelines, an internationally recognized gold standard that guarantees the safety, quality, and pharmaceutical viability of agricultural products.

From Vine to Vials: An Agricultural Masterpiece

To achieve this level of elite production, Hybrida Farms executed a brilliant strategic transformation. The state-of-the-art cultivation facility was developed by modernizing a legacy agricultural site that previously served as one of Central America's largest USDA-certified tomato exporting operations.

By leveraging pre-existing world-class agricultural infrastructure and upgrading it for pharmaceutical production, the company efficiently bridged Costa Rica’s rich farming heritage with the high-tech demands of modern botanical medicine.

A Lucrative Economic Horizon for Costa Rica

This inaugural EU export is much more than a single shipment; it represents the dawn of a new, highly lucrative era for the Costa Rican economy.

Costa Rica has long enjoyed a stellar global reputation for its agricultural excellence, scientific rigor, and unwavering commitment to environmental responsibility. By transitioning these national strengths into the high-value pharmaceutical-grade cannabis sector, Costa Rica is beautifully positioned to capture a significant share of the rapidly expanding European market.

As demand for premium, highly regulated medical cannabis continues to surge across Europe, Costa Rica’s newly proven export pipeline promises a wealth of economic opportunity, international investment, and agricultural innovation for years to come.